The Scoliosis Research Society has introduced a new 3D classification framework for Adolescent Idiopathic Scoliosis (AIS), known as the SRS–Lenke–Aubin 3D classification. Published in Spine Deformity, the system builds on the legacy Lenke classification by incorporating the transverse plane—long overlooked in routine clinical assessments. Designed to capture vertebral rotation and regional axial curve orientation, the system aims to correct for the two-dimensional limitations of existing methods and align scoliosis care with modern imaging and surgical technologies.
This development marks a strategic inflection point for spinal deformity research and practice, particularly as AIS treatment shifts toward patient-specific interventions that rely on richer anatomical context. The system was validated in a cohort of 285 surgically treated AIS patients and is now positioned for broader dissemination through software tools and educational resources backed by the SRS.
Why this shift reflects an overdue realignment between clinical descriptors and 3D pathology
The motivation behind the SRS–Lenke–Aubin 3D system stems from a fundamental mismatch between the true nature of AIS and the frameworks used to describe it. Adolescent Idiopathic Scoliosis is not a planar condition—it is a three-dimensional deformity involving lateral curvature, axial rotation, and sagittal misalignment. Yet the predominant clinical tools in use today—most notably the Cobb angle and traditional Lenke classification—offer only two-dimensional snapshots that omit key rotational elements.
This discrepancy has real-world consequences. Clinicians and surgical teams increasingly rely on 3D imaging modalities for planning, and devices such as patient-specific rods and robotic navigation systems depend on high-fidelity modeling. Yet until now, the classification systems informing treatment planning have remained anchored in coronal and sagittal perspectives.
By introducing a formal structure to account for transverse plane deformity, the new 3D classification attempts to bridge this gap without requiring clinics to abandon familiar workflows. According to clinicians tracking the field, this design choice—compatibility with current practice—is likely to be a major factor in accelerating adoption.
What the SRS 3D system changes for surgical planning and outcome variability in AIS
The implications of this classification go beyond semantics. One of the persistent challenges in AIS surgery has been variability in outcomes among patients classified under the same Lenke type. This intra-type heterogeneity has often been attributed to unmeasured factors, with axial rotation and regional curve asymmetry cited as key contributors.
The new system addresses this by offering a more granular subtyping that captures vertebral rotation patterns and curve morphology across all three planes. For surgeons, this enables more precise risk stratification, device selection, and surgical planning—particularly in complex cases where 2D descriptors fall short. For example, the decision to employ vertebral body tethering, differential rod stiffness, or asymmetric derotation techniques depends heavily on a full understanding of 3D curve dynamics.
Industry observers also suggest that the classification could eventually serve as a foundation for AI-based predictive models, which require structured, high-dimensional input data to model surgical outcomes and simulate long-term curve progression.
How this update could reshape research design and trial stratification in AIS interventions
Beyond the clinic, the SRS–Lenke–Aubin 3D classification could play a significant role in improving research quality and trial design across AIS studies. Device manufacturers and research consortia have struggled with cohort heterogeneity in studies of surgical implants, fusionless techniques, and bracing technologies. Even when using traditional Lenke types for stratification, unexplained variance in outcomes often limits the interpretability of findings.
The 3D classification offers a more nuanced patient segmentation approach, which could reduce noise in trial arms and enable better comparison between device platforms. Regulatory watchers believe this will become increasingly relevant as novel implants that target motion preservation or derotation begin to seek market authorization.
Furthermore, harmonizing clinical classification with imaging-derived metrics could also support the development of digital twins and simulation-based evidence generation. With regulatory agencies like the U.S. Food and Drug Administration exploring how in silico models can support orthopedic approvals, a structured 3D classification may become a key input requirement.
Where the classification fits within the broader evolution of 3D imaging and navigation
The rise of 3D imaging technologies such as EOS imaging systems, biplanar X-rays, and low-dose CT has opened the door to more precise deformity analysis. Yet until now, there has been a disconnect between what the imaging systems can visualize and what the classification systems can encode. The SRS–Lenke–Aubin framework brings these domains into closer alignment.
Clinicians working in high-volume AIS centers have already incorporated transverse metrics into informal planning, often using custom software or visual estimation. This classification formalizes that practice and enables standardization across institutions, which is especially critical for multicenter research and benchmarking initiatives.
Moreover, surgical navigation platforms and robotic systems increasingly rely on preloaded 3D templates to execute screw trajectories and correction maneuvers. Integrating the new classification into these planning systems could further personalize surgical strategy, reducing reliance on intraoperative improvisation and improving reproducibility.
What still stands in the way of widespread clinical and research adoption
Despite the strengths of the new system, several hurdles remain. First is imaging access. While 3D-capable imaging is growing more common, it remains unevenly distributed—especially in low-resource or rural settings. Centers without biplanar systems or advanced reconstruction capabilities may struggle to extract the required metrics without additional investment.
Second is standardization and training. Vertebral rotation is notoriously difficult to measure consistently, and interobserver variability remains a concern. Clinicians and researchers will need access to robust measurement protocols and digital tools to minimize subjectivity.
Third is workflow burden. Any new classification risks being viewed as an additional layer of complexity, especially by busy community orthopedists. The SRS has acknowledged this and is reportedly developing automated tools and educational modules to ease implementation.
Until these support systems are in place, early adoption may be limited to academic centers and high-volume scoliosis practices.
Broader implications for regulatory alignment and post-market tracking in spine care
As scoliosis treatment becomes increasingly personalized and technology-driven, regulators are likely to expect stronger alignment between the anatomical descriptors used in trial designs and the real-world complexity of the condition. The SRS–Lenke–Aubin 3D system could become a preferred standard in submissions that involve spinal deformity devices or digital planning software.
Post-market surveillance systems, too, may benefit from incorporating the 3D classification. By enabling more precise curve tracking over time, it can improve adverse event reporting and help identify device performance trends across specific curve patterns. Some industry analysts also suggest that insurers and payers may find the system useful in justifying differentiated reimbursement pathways for patients with more complex 3D deformities.
A classification system that may future-proof scoliosis care
In its current form, the SRS–Lenke–Aubin 3D classification represents an evolutionary—not revolutionary—step in scoliosis care. It does not discard existing systems but builds upon them, adding a long-missing axis of understanding without forcing radical practice change. Its success will depend on how effectively it can integrate into clinical software, educational platforms, and regulatory frameworks.
If that integration succeeds, the system could help usher in a new era of truly three-dimensional, patient-specific AIS treatment—closing the gap between what clinicians can see and what they can formally describe.